Definitive Contract 75N93019C00019
Award Date
8/8/19
Potential Completion Date
8/7/21
Potential Value
$140K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Visby Medical, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Economy Act
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
Visby Medical, Inc. was awarded a definitive contract valued at $9.5 million by the National Institutes of Health's National Heart Lung and Blood Institute to deliver a single-use, fully-integrated, rapid, automated reverse transcription polymerase chain reaction in vitro diagnostic test. The contract is associated with the Rapid Acceleration of Diagnostics program and will support Visby Medical's development and delivery of its rapid point-of-care COVID-19 diagnostic test. Work will be...
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
This is a firm fixed-price contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services, to Ai Biosciences, Inc., a small disadvantaged business, through the Small Business Innovation Research (SBIR) program. The contract is for the development of a point-of-care diagnostic test to detect gonorrhea and determine antimicrobial susceptibility. The potential value of the contract is $299,652.00, and the period of performance runs from August 8,...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $920,600 firm fixed price definitive contract to Visby Medical, Inc. of San Jose, California. The contract calls for Visby Medical to provide handheld devices and cartridges to support COVID-19 testing efforts under the Coronavirus National Interest Action Code. Performance will take place in San Jose through March 2021. As the sole awardee, Visby Medical will deliver its point-of-care...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, for COVID-19 antibody test kits. The award, with a potential value of $102,862.00, was a total small business set-aside. The kits procured include the V-PLEX SARS-CoV-2 Panel 23 (IgG) Kit (25 PL) and the V-PLEX COVID-19 Coronavirus Panel 2 (IgG) Kit (25...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $299,968 Small Business Innovation Research (SBIR) Phase I contract to Vitruvian Bio, LLC, a small disadvantaged and woman-owned business. The contract is for the development of an "Electrochemical Self-Monitoring Device for Rapid Nucleic Acid Based Testing of HIV-1". This specialized medical research and diagnostic technology...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $21,785.55 firm fixed-price purchase order to Meso Scale Diagnostics LLC, doing business as Meso Scale Discovery, located in Potomac, Maryland. Under the terms of the award, Meso Scale Discovery will provide V-PLEX SARS-COV-2 PANEL 34 (IGG) KITS to the agency. The contract has a period of performance from August 23, 2023 through September 30, 2023 to...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase II contract to Nowdiagnostics, Inc., a small disadvantaged business, for a multiplexed remote system for filovirus disease surveillance. The firm-fixed-price contract, with a potential value of $2,431,860.00, was awarded on September 20, 2018 and has a completion date of September 30, 2022....
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Qoolabs Inc., a self-certified small disadvantaged business, to develop rapid point-of-care detection tests for serologic status of individuals for cytomegalovirus (CMV) and herpes simplex virus (HSV) infections. The $225,000.00 fixed-price contract has a period of performance through July 31, 2018,...
This federal contract award to Inbios International Inc., a minority-owned business based in Seattle, Washington, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The $749,998 firm fixed-price contract supports research and development (R&D) of an antibody diagnostic for COVID-19. The contract was issued under a Broad Agency Announcement (BAA) solicitation from ASPR's Division of...